An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial of Seroquel SR [sustained release quetiapine] Co-Administration for SSRI [Selective Serotonin Reuptake Inhibitor]-Resistant, Comorbid Panic Disorder.

Trial Profile

An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial of Seroquel SR [sustained release quetiapine] Co-Administration for SSRI [Selective Serotonin Reuptake Inhibitor]-Resistant, Comorbid Panic Disorder.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Jan 2016

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Panic disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Jul 2012 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
    • 03 Jul 2012 Actual patient number is 26 according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top